ALPHA AESTHETICS & HEALTH
SEMAGLUTIDE · TIRZEPATIDE · PHYSICIAN-SUPERVISED · ALPHARETTA, GA
BOOK A CONSULTATIONFINALLY — A MEDICAL SOLUTION
For millions of people, weight loss isn't a willpower problem — it's a hormonal one. GLP-1 medications like Semaglutide and Tirzepatide work by regulating hunger hormones and slowing digestion, making it significantly easier to eat less and lose weight consistently.
At Alpha Aesthetics & Health, our physician-supervised weight loss program ensures you're using the right medication at the right dose — with clinical oversight every step of the way. We start with a consultation, dial in your protocol, and adjust based on your progress and how your body responds.
This is real medicine. Real results. Supervised by our medical team in Alpharetta, GA.
BOOK MY CONSULT — $75WHO IS A CANDIDATE?
A full consultation with our medical team determines eligibility. Book yours today.
OUR MEDICATIONS
Semaglutide (the active ingredient in Ozempic® and Wegovy®) is a GLP-1 receptor agonist that mimics a natural hormone to reduce appetite, slow stomach emptying, and regulate blood sugar.
Clinical trials show an average of 15% body weight reduction over 68 weeks. Our protocol starts at a low dose and titrates up based on your response and tolerance.
Tirzepatide (the active ingredient in Mounjaro® and Zepbound®) is a dual GLP-1 and GIP receptor agonist — meaning it targets two hunger hormones simultaneously for even greater weight loss results.
Studies show up to 22% body weight reduction. Available in multiple doses from 2.5mg up to 15mg, titrated under physician supervision.
YOUR JOURNEY
Meet with our medical team to review your health history, goals, and determine if GLP-1 therapy is right for you.
We prescribe the right medication and starting dose for your body type and metabolic profile.
Regular check-ins to monitor your progress, adjust dosing, and provide clinical support as you lose weight.
We work with you to maintain your results and support lasting lifestyle changes beyond medication.
TRANSPARENT PRICING